What it is
Omeprazole was the first proton pump inhibitor (PPI) to be marketed, in 1988. Today it is one of the most dispensed medicines in the world and the reference stomach protector in Spain.
It works by irreversibly blocking the H+/K+-ATPase pump of the gastric parietal cells, reducing acid production by up to 90%. Its effect is not immediate but progressive: it takes several days to reach full efficacy.
Irreversible inhibition of the proton pump
Omeprazole is a prodrug: it is activated in the acidic environment of the parietal cell's secretory canaliculus.
- It is converted into an active sulfenamide in the acidic environment of the parietal cell.
- It binds covalently (irreversibly) to the H+/K+-ATPase → it blocks H+ secretion into the stomach.
- Acid secretion only recovers when new pumps are made: that takes 18–24 hours.
- That is why the effect builds up: the maximum is reached 3–5 days after starting treatment.
- It is not an antacid: it does not neutralise acid already present, it reduces its production.
At the counter
When to recommend it
- Gastric protection with NSAIDs, especially over 65, with a history of ulcer or in prolonged treatment
- Gastro-oesophageal reflux disease (GORD): relief of heartburn and regurgitation
- Active peptic ulcer (gastric or duodenal)
- Gastric protection with systemic corticosteroids
- Erosive oesophagitis
- H. pylori eradication treatment (part of the combined therapy)
When not to
- Do not use it as an on-the-spot antacid: alginates or fast-acting antacids exist for that
- Do not continue longer than necessary: periodically review whether it is still indicated
- Do not assume that all heartburn needs long-term omeprazole without a diagnosis
- Caution with clopidogrel: omeprazole inhibits CYP2C19 and reduces its activation (use pantoprazole if a PPI is needed in this context)
Warnings
- Caution LONG-TERM USE: prolonged use (>1 year) is associated with deficiencies of magnesium, vitamin B12, calcium and iron. Review blood tests periodically in patients on long-term PPIs.
- Caution CLOPIDOGREL: omeprazole significantly inhibits CYP2C19, which activates clopidogrel. It may reduce its antiplatelet effect. If a PPI is indicated with clopidogrel, prefer pantoprazole.
- Caution OSTEOPOROSIS: long-term PPI use has been associated with a higher risk of hip fracture in older people, probably through reduced calcium absorption.
- Caution INFECTIONS: lower stomach acid increases the risk of gastrointestinal infections (Clostridioides difficile, Salmonella, Campylobacter) by removing the acid barrier.
- Worth knowing IT IS NOT NEUTRAL: the perception that omeprazole 'does no harm' has led to overuse. Several studies indicate that a large share of long-term PPI treatments have no clear indication.
Pharmacokinetics
- Absorption
- Oral: absorbed in the small intestine (stomach acid would destroy it). That is why it comes in capsules with enteric-coated granules or gastro-resistant tablets. Do not open, split or chew. Bioavailability of 35–65%, rising with repeated doses.
- Distribution
- High plasma protein binding (95%). It concentrates selectively in the gastric parietal cells, its target. It does not significantly cross the blood–brain barrier.
- Metabolism
- Hepatic, mainly via CYP2C19 (and to a lesser extent CYP3A4). There are genetic polymorphisms: 'poor metabolisers' (around 2–5% of Europeans and considerably more among people of Asian origin) have much higher concentrations and a longer effect. It interacts with drugs that use CYP2C19.
- Elimination
- Renal (80%) and biliary (20%) as inactive metabolites. Short half-life: 0.5–1 hour. But the effect lasts 24 h because the pump block is irreversible.
Omeprazole vs fast-acting antacids
| Aspect | Omeprazole | Antacids (alginate, aluminium/magnesium hydroxide) |
|---|---|---|
| Mechanism | Blocks acid production | Neutralises acid already present |
| Onset of action | Hours (maximum effect at 3–5 days) | Minutes |
| Duration | 24 hours (irreversible block) | 1–3 hours |
| Ideal indication | Treatment and prevention over the medium term | Occasional, immediate relief |
| Long-term use | Possible with monitoring | Not recommended (side effects) |
| Price | Low (generics available) | Variable |
Omeprazole to treat and prevent; an antacid to relieve in the moment. Explaining this to the patient avoids frustration: whoever expects an immediate effect from omeprazole will not find it.
Self-assessment
Three questions. When you check your answers you will see the explanation for each one.
-
Omeprazole reduces acid production but does not neutralise the acid already there. Its maximum effect takes several days. For immediate relief of heartburn, an alginate or a classic antacid is much more suitable. Both can be used together.
-
Omeprazole is destroyed by acid. The capsules contain granules with an enteric coating that protects them in the stomach and releases them in the small intestine, where they are absorbed. Splitting or chewing them removes that protection.
-
Omeprazole significantly inhibits CYP2C19, the enzyme that activates clopidogrel. Taken together, clopidogrel's antiplatelet effect can be reduced. Pantoprazole has a weaker inhibitory effect on CYP2C19 and is the preferred option in this context.
Training content. It does not replace the summary of product characteristics or clinical judgement.